Overview

Assessing Myocardial Blood Flow and Blood Flow Reserve by Transoesophageal Echocardiography (TEE)

Status:
Withdrawn
Trial end date:
2008-12-01
Target enrollment:
0
Participant gender:
All
Summary
Until today it was not possible to reliably assess the function of a new bypass, i.e., to measure myocardial perfusion. Measuring intramyocardial blood flow directly after revascularisation would greatly improve the assessment of graft function. With transthoracic contrast echocardiography, myocardial perfusion can be reliably assessed, as it has been shown in numerous studies. In the first part of the study the investigators will clarify methodological aspects of contrast echocardiography. In the second part they will analyze the validity of contrast TEE in the operating room.
Phase:
Phase 1/Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University Hospital, Basel, Switzerland
Criteria
Inclusion Criteria:

- Part I: Patients with angiographically normal coronary vessels undergoing elective
valve surgery or patients with coronary artery disease (CAD) who are planned for
elective CABG surgery

- Part II: Patients with CAD who are planned for elective CABG surgery and who had SPECT
including adenosine for hyperemia before surgery

Exclusion Criteria:

- No consent

- Acute coronary syndrome

- Acute heart failure

- Left ventricular ejection fraction < 30%

- Pronounced pulmonary artery hypertension

- Known adverse reaction against Optison or SonoVue or their components

- Severe renal or hepatic insufficiency

- Severe obstructive lung disease